Bioneer A/S
↗Hørsholm, Denmark
Bioneer A/S is a Danish innovative specialty Contract Research Organization (CRO) that serves as a strategic R&D partner to the global biotech and pharmaceutical industries. Founded in 1982, the company specializes in creating customized research service solutions, particularly in the early stages of drug development, including mechanism of action studies, efficacy, and safety profiling.
Bioneer operates as a not-for-profit organization and is a subsidiary of the Technical University of Denmark (DTU). It is approved by the Danish Ministry of Science and Technology as an authorized provider of technological services (GTS). The company operates out of two main sites in the Copenhagen area, including facilities in the Scion-DTU Science Park, focusing on advanced in-vitro disease modeling, recombinant protein production, and molecular detection services.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:1982
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics, Recombinant proteins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Technical University of Denmark (DTU)
Key Partnerships:Biotech and pharmaceutical companies globally (as a service partner)
COMPETITION
Position:Niche Player
Competitors:Charles River Laboratories, Eurofins Scientific, Evotec
LEADERSHIP
Key Executives:
Boye Schnack Nielsen - Senior Scientist/Key Personnel
LINKS
Website:bioneer.dk
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Bioneer A/S and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bioneer A/S. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.